135 related articles for article (PubMed ID: 6203136)
1. [Tumor markers--possibilities and limitations].
Rose H; Saul G; Wolf G; Moldenhauer H; Kehrberg G
Radiobiol Radiother (Berl); 1984; 25(1):7-19. PubMed ID: 6203136
[No Abstract] [Full Text] [Related]
2. Serum tumor markers.
Klee GG; Go VL
Mayo Clin Proc; 1982 Feb; 57(2):129-32. PubMed ID: 6172679
[No Abstract] [Full Text] [Related]
3. [Primary mesoblastoma of the mediastinum. Pathological criteria of its diagnosis and value of tumor markers: AFP, beta HCG and SP 1].
Wihlm JM; Warter A; Lion R; Morand G; Witz JP
Ann Chir; 1988; 42(2):149-53. PubMed ID: 2453135
[No Abstract] [Full Text] [Related]
4. [Significance of tumor markers in clinical oncology].
Gericke D; Drahovsky D
Med Klin; 1979 May; 74(19):701-9. PubMed ID: 88005
[No Abstract] [Full Text] [Related]
5. [Diagnostic criteria for the tumor markers of the body fluids].
Konishi K; Nakagawa S; Watanabe K; Takamura S
Rinsho Byori; 1983 Sep; 31(9):945-54. PubMed ID: 6198536
[No Abstract] [Full Text] [Related]
6. [Serum markers in malignant diseases].
Peter HH
Med Lab (Stuttg); 1981 Nov; 34(11):262-71. PubMed ID: 6176842
[No Abstract] [Full Text] [Related]
7. Immunocytochemical evaluation of human esophageal neoplasms and preneoplastic lesions for beta-chorionic gonadotropin, placental lactogen, alpha-fetoprotein, carcinoembryonic antigen, and nonspecific cross-reacting antigen.
Burg-Kurland CL; Purnell DM; Combs JW; Hillman EA; Harris CC; Trump BF
Cancer Res; 1986 Jun; 46(6):2936-43. PubMed ID: 2421889
[TBL] [Abstract][Full Text] [Related]
8. [Tumor markers].
Cappelaere P
Rev Prat; 1988 Jun; 38(17):1058-63. PubMed ID: 2457249
[No Abstract] [Full Text] [Related]
9. Editorial: When is a tumor marker not a tumor marker?
Vaitukaitis JL
N Engl J Med; 1975 Dec; 293(26):1370-1. PubMed ID: 52844
[No Abstract] [Full Text] [Related]
10. Significance of CEA, AFP, SP1 and HCG as tumor markers in ovarian carcinoma.
Pulay T; Csömör S; Mészáros K; Szarka G; Csabay L; Szinnyai A
Neoplasma; 1987; 34(5):595-600. PubMed ID: 2447510
[TBL] [Abstract][Full Text] [Related]
11. [Clinical value of the determination of pregnancy proteins in the blood].
Kamińska JA; Ozuch B
Ginekol Pol; 1981 Apr; 52(4):381-91. PubMed ID: 6167491
[No Abstract] [Full Text] [Related]
12. [Carcinoembryonic antigen, alpha-fetoprotein and human chorionic gonadotropin producing gastric cancer].
Honda T; Katusima S; Tokuda Y; Matuda K; Oonisi Y; Taniguchi T; Oomoto J; Kawaguchi Y
Nihon Naika Gakkai Zasshi; 1984 Apr; 73(4):521-6. PubMed ID: 6206171
[No Abstract] [Full Text] [Related]
13. [Sense and nonsense of tumor markers in practice].
Joss R; Cerny T
Schweiz Med Wochenschr; 1990 May; 120(19):693-703. PubMed ID: 1693445
[TBL] [Abstract][Full Text] [Related]
14. Clinical utility of oncofetal proteins and hormones as tumor markers.
Garrett PE; Kurtz SR
Med Clin North Am; 1986 Nov; 70(6):1295-306. PubMed ID: 2431237
[TBL] [Abstract][Full Text] [Related]
15. [Tumor markers. Current knowledge and practical usefulness].
Papaleo G; Sacerdoti G; Zito GA
Recenti Prog Med; 1982 Apr; 72(4):504-30. PubMed ID: 6183719
[No Abstract] [Full Text] [Related]
16. [Antigens of cancerous origin in various neoplastic diseases].
Zangerle PF; Reuter A; Hendrick JC; Nogarede J; Colin C; Franchimont P
Bull Cancer; 1976; 63(4):689-98. PubMed ID: 66076
[No Abstract] [Full Text] [Related]
17. Tumor markers in testis tumors.
Kansu E
Turk J Pediatr; 1984; 26(1-4):277-83. PubMed ID: 6085661
[No Abstract] [Full Text] [Related]
18. Diagnostic significance and clinical application of tumour-associated antigens in man with special reference to the carcinoembryonic antigen.
Wagener C; Breuer H
J Clin Chem Clin Biochem; 1977 Oct; 15(10):529-43. PubMed ID: 72783
[No Abstract] [Full Text] [Related]
19. [Immunohistochemical study of tumor markers of malignant germ cell tumors in the mediastinum].
Miyake M; Ito M; Sumitomo S; Mitsuoka A; Taki T; Hitomi S
Nihon Kyobu Geka Gakkai Zasshi; 1987 Jun; 35(6):792-8. PubMed ID: 2443586
[No Abstract] [Full Text] [Related]
20. Biological markers of human tumors and monitoring of cancer treatment.
Tanneberger S; Nissen E; Ziegenbein R
Arch Geschwulstforsch; 1979; 49(6):528-34. PubMed ID: 94534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
